Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daglutril in type 2 diabetics with nephropathy and hypertension
NCT00160225Phase 2Completed
- Sponsor
- Solvay
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Daglutril in diabetic nephropathy (DN), sponsored by Solvay. Started Jul 2005; status: completed.
02
Drugs
Daglutril
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00160225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160225.